Esthesioneuroblastoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +) |
||
| Line 30: | Line 30: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 02:24, 9 August 2012
| Esthesioneuroblastoma | |
| ICD-10 | C30.0 |
|---|---|
| ICD-9 | 160.0 |
| ICD-O: | M9522/3 |
| OMIM | 133450 |
| DiseasesDB | 32047 |
| MeSH | D018304 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Esthesioneuroblastoma is a form of neuroblastoma presenting near the nasal cavity.
Loss of vision is possible.[1]
References
- ↑ Sharma S, Sharma MC, Johnson MH, Lou M, Thakar A, Sarkar C (2007). "Esthesioneuroblastoma - a clinicopathologic study and role of DNA topoisomerase alpha" (PDF). Pathol. Oncol. Res. 13 (2): 123–9. doi:PAOR.2007.13.2.0123 Check
|doi=value (help). PMID 17607373.
Template:Central nervous system tumors